Alleviating the unwanted effects of oxidative stress on Aβ clearance: a review of related concepts and strategies for the development of computational modelling
Abstract Treatment for Alzheimer’s disease (AD) can be more effective in the early stages. Although we do not completely understand the aetiology of the early stages of AD, potential pathological factors (amyloid beta [Aβ] and tau) and other co-factors have been identified as causes of AD, which may...
Main Authors: | Sarawoot Somin, Don Kulasiri, Sandhya Samarasinghe |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Translational Neurodegeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40035-023-00344-2 |
Similar Items
-
The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells
by: Wenjun Cai, et al.
Published: (2023-02-01) -
Photostimulation of lymphatic clearance of β-amyloid from mouse brain: a new strategy for the therapy of Alzheimer’s disease
by: Dongyu Li, et al.
Published: (2023-12-01) -
Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01) -
Effect of rosiglitazone on amyloid precursor protein processing and Aβ clearance in streptozotocin-induced rat model of Alzheimer’s disease
by: Li Wang, et al.
Published: (2017-05-01) -
The “Cerebrospinal Fluid Sink Therapeutic Strategy” in Alzheimer’s Disease—From Theory to Design of Applied Systems
by: Thomas Gabriel Schreiner, et al.
Published: (2022-06-01)